NCT04644796View on ClinicalTrials.gov

A Randomized Trial of Exparel vs Saline in Opioid Reduction of Pain Management Following Lumbar Spine Surgeries.

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 10, 2021

Primary Completion Date

June 13, 2022

Study Completion Date

June 13, 2022

Conditions
Lumbar Spine Degeneration
Interventions
DRUG

saline 0.9%

Patients included in the placebo group will have their incisional site infused, targeting the paraspinal muscles with sterile saline at the end of their surgery.

DRUG

Liposomal bupivacaine

Patients included in the treatment group will have their incisional site infused, targeting the paraspinal muscles with liposomal bupivacaine at the end of their surgery.

Trial Locations (1)

65211

Missouri Orthopaedic Institute, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER

NCT04644796 - A Randomized Trial of Exparel vs Saline in Opioid Reduction of Pain Management Following Lumbar Spine Surgeries. | Biotech Hunter | Biotech Hunter